Stock comparison
LeMaitre Vascular
Masimo
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LMAT
LeMaitre Vascular
Market cap
$2.32B
Sector
Healthcare
MASI
Masimo
Market cap
$9.35B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LMAT | MASI | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 39D | LMAT |
| Benjamin Graham | 81A | 66B | LMAT |
| Philip Fisher | 73B | 40D | LMAT |
| Peter Lynch | 59C | 26F | LMAT |
| Joel Greenblatt | 48D | 53C | MASI |
| Charlie Munger | 60C | 42D | LMAT |
| Terry Smith | 61C | 33F | LMAT |
Side-by-side metrics
| Metric | LMAT | MASI |
|---|---|---|
| Market cap | $2.32B | $9.35B |
| P/E (TTM) | 37.1x | 122.1x |
| EV/EBIT | 36.6x | 31.0x |
| ROIC (TTM) | 9.43% | 18.28% |
| Gross margin | 72.39% | 61.73% |
| Net margin | 24.35% | 4.9% |
| Revenue CAGR 5y | 12.75% | 5.36% |
| EPS CAGR 5y | 19.04% | - |
| Debt / Equity | 0.5x | 0.6x |
| Dividend yield | 0.84% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LMAT leads on
- Dividend yield0.84%vs 0.0%+100%
- Net margin24.35%vs 4.9%+80%
- P/E (TTM)37.1xvs 122.1x+70%
- Revenue CAGR 5y12.75%vs 5.36%+58%
MASI leads on
- Market cap$9.35Bvs $2.32B+75%
- ROIC (TTM)18.28%vs 9.43%+48%
- EV/EBIT31.0xvs 36.6x+15%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.